Annabelle
Analyst
Stiefel
Equibles does not estimate personal net worth.
About Annabelle
Annabelle is recorded as Analyst at Stiefel. Annabelle has spoken on 2 investor events across 2 companies, most recently for Mineralys Therapeutics, Inc. on November 12, 2026. Those appearances were for Mineralys Therapeutics, Inc. (MLYS) and Trevi Therapeutics, Inc. (TRVI). The companies whose calls Annabelle spoke on are classified in the Healthcare sector.
Annabelle on recent calls
“December 22nd is obviously approaching very Very quickly, and you have a... I would say a pretty impressive large trial package. So how are you seeking to leverage that wealth of data that you have to support a differentiated label?”
“Happy to have Jennifer Good, CEO of Trevi, with us, as well as Dave Hastings, CFO. And as you know, Trevi is now the solo operator in the chronic cough indication.”
Affiliation history
-
Stiefel
Analyst
Transcript header (unverified)
Current